Qing Shi

1.2k citations
37 papers · 973 indexed · h-index 15
Topics
Advanced Adaptive Filtering Techniques (5 papers)Connective tissue disorders research (3 papers)Protease and Inhibitor Mechanisms (3 papers)

In The Last Decade

Qing Shi

36 papers receiving 955 citations

Peers

Qing Shi
Comparison fields: 5 of 111
  • Molecular Biology 428
  • Oncology 249
  • Cancer Research 147
  • Cell Biology 131
  • Rheumatology 88
Replace Yosuke Kawase with:
Yosuke Kawase Japan
Yuepeng Wang China
Tsung‐Lin Cheng Taiwan
Jie Bao China
Attila Zalatnai Hungary
Yang Jin China
Mengwei Li China
Yuanyuan Wu China
Xi Li China
Ximei Zhang China
Qing Shi relative to Yosuke Kawase Japan Yosuke Kawase's profile →
Citations per field
00.5×2.8×
Yosuke Kawase · 1×
Citations per year

Countries citing papers authored by Qing Shi

Since Specialization
Citations

This map shows the geographic impact of Qing Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Shi more than expected).

Fields of papers citing papers by Qing Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Shi. The network helps show where Qing Shi may publish in the future.

Co-authorship network of co-authors of Qing Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Shi. A scholar is included among the top collaborators of Qing Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Shi. Qing Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 2
4 1
5 5
6 9
7 4
8 1
9 1
10 4
11 16
12 18
13 19
14 60
15 136
16 109
17
Secreted protein acidic and rich in cysteine (SPARC) activates focal adhesion kinase and integrin-linked kinase to induce AKT-dependent glioma survival and invasion
2
18 91
19 132
20 142

About Qing Shi

Qing Shi is a scholar working on Hepatology, Cancer Research and Toxicology, having authored 37 papers that have together received 973 indexed citations. Recurring topics across this work include Advanced Adaptive Filtering Techniques (5 papers), Connective tissue disorders research (3 papers) and Protease and Inhibitor Mechanisms (3 papers). The work is most often cited by research in Immunology and Allergy (72 citations), Cancer Research (147 citations) and Oncology (249 citations). Qing Shi has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Jeremy N. Rich, Darell D. Bigner, Audrey Minden, Primal de Lanerolle, Jian Qu, Michael P. Sheetz, Takayuki Nishizaka, Changqing Yang, Thomas J. Cummings and Xiao‐Fan Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026